| Drug Name: | homocysteine (454-29-5) |
|---|---|
| PubChem ID: | 778 |
| SMILES: | C(CS)C(C(=O)O)N |
| InchiKey: | FFFHZYDWPBMWHY-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 135.188 |
| LogP | : | -0.2818 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 3 |
| Total Polar Surface Area | : | 63.32 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Apoptosis | Protein tyrosine phosphatase (Q05209) | PTPase(s) plays an integral role in the induction of EC apoptosis upon exposure to homocysteine and/or adenosine@ possibly by the attenuation of p38alpha activity [ ADR Type 2 ] | Adenosine induces endothelial apoptosis by activating protein tyrosine phosphatase: a possible role of p38alpha |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|